Literature DB >> 2071489

Structural studies on avidinorubicin, a novel anthracycline with platelet aggregation inhibitory activity.

M Aoki1, H Shirai, N Nakayama, Y Itezono, M Mori, T Satoh, S Ohshima, J Watanabe, K Yokose, H Seto.   

Abstract

Avidinorubicin (MW 1,214, C60H86N4O22) was isolated from the cultured broth of strain NR0576 (which was identified as Streptomyces avidinii Stapley et al.) by butyl alcohol extraction, Sephadex LH-20 column chromatography and preparative HPLC. Avidinorubicin inhibited thrombin-induced platelet aggregation with an IC50 being 7.9 microM and was determined to be a novel anthracycline possessing two units of a new aminosugar, avidinosamine, in place of two decilonitrose groups in decilorubicin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2071489     DOI: 10.7164/antibiotics.44.635

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Phallusialides A-E, Pyrrole-Derived Alkaloids Discovered from a Marine-Derived Micromonospora sp. Bacterium Using MS-Based Metabolomics Approaches.

Authors:  Fan Zhang; Doug R Braun; Shaurya Chanana; Scott R Rajski; Tim S Bugni
Journal:  J Nat Prod       Date:  2019-12-03       Impact factor: 4.050

3.  An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria.

Authors:  Georgina Cox; Kalinka Koteva; Gerard D Wright
Journal:  J Antimicrob Chemother       Date:  2014-03-13       Impact factor: 5.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.